Article info
PDFInflammatory bowel disease
Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial
- Professor W Kruis, Evangelisches Krankenhaus Kalk, Buchforststr 2, D-51103, Cologne, Germany; sallhoff{at}evkk.de
Citation
Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial
Publication history
- Revised July 26, 2008
- Accepted September 2, 2008
- First published October 2, 2008.
Online issue publication
October 26, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Kruis et al 2009 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.